Federal Register / Vol. 80, No. 243 / Friday, December 18, 2015 / Notices 79041 

ENVIRONMENTAL PROTECTION 

AGENCY 

[ER–FRL–9024–5] 

Environmental Impact Statements; 

Notice of Availability 

Responsible Agency: Office of Federal 

Activities, General Information (202) 

564–7146 or http://www2.epa.gov/nepa. 

Weekly receipt of Environmental Impact 

Statements 

Filed 12/07/2015 Through 12/11/2015 

Pursuant to 40 CFR 1506.9. 

Notice 

Section 309(a) of the Clean Air Act 

requires that EPA make public its 

comments on EISs issued by other 

Federal agencies. EPA’s comment letters 

on EISs are available at: http://

cdxnodengn.epa.gov/cdx-nepa-public/

action/eis/search. 

EIS No. 20150350, Draft, NMFS, FL, 

Regional Management of Recreational 

Red Snapper Amendment 39 to the 

Fishery Management Plan for the Reef 

Fish Resources in the Gulf of Mexico, 

Comment Period Ends: 02/01/2016, 

Contact: Roy E. Crabtree 727–824– 

5301. 

EIS No. 20150351, Final, USFWS, TX, 

Southern Edwards Plateau Habitat 

Conservation Plan, Review Period 

Ends: 01/19/2016, Contact: Adam 

Zerrenner 512–490–0057. 

EIS No. 20150352, Final, USFS, MT, 

Montanore Project, Review Period 

Ends: 01/19/2016, Contact: Lynn 

Hagarty 406–283–7642. 

EIS No. 20150353, Draft, FRA, MD, Draft 

Section 4(f) Evaluation for the 

Baltimore & Potomac Tunnel Project, 

Comment Period Ends: 02/05/2016, 

Contact: Michelle W. Fishburne 202– 

293–0398. 

EIS No. 20150354, Final, BR, CA, Upper 

Truckee River and Marsh Restoration 

Project, Review Period Ends: 01/19/

2016, Contact: Rosemary Stefani 916– 

978–5045. 

EIS No. 20150355, Final, USN, OR, 

Military Readiness Activities at Naval 

Weapons Systems Training Facility 

Boardman, OR, Review Period Ends: 

01/19/2016, Contact: Amy Burt 360– 

396–0403. 

EIS No. 20150356, Final, APHIS, PRO, 

Carcass Management During a Mass 

Animal Health Emergency, Review 

Period Ends: 01/19/2016, Contact: 

Lori P. Miller 301–851–3512. 

Amended Notices 

EIS No. 20150357, Adoption, NOAA, 

OR, ADOPTION—Southern Flow 

Corridor Project, Contact: Patricia A. 

Montanio 301–427–8600. 

The U.S. Department of Commerce’s 

National Oceanic and Atmospheric 

Administration (NOAA) is adopting the 

Federal Emergency Management 

Agency’s FEIS #20150296, filed 10/22/ 

2015 with EPA. NOAA was a 

cooperating agency for the above 

project, therefore recirculation of the 

document is not necessary under 

Section 1506.3(c) of the Council on 

Environmental Quality Regulations. 

Dated: December 15, 2015. 

Karin Leff, 

Acting Director, NEPA Compliance Division, 

Office of Federal Activities. 

[FR Doc. 2015–31903 Filed 12–17–15; 8:45 am] 

BILLING CODE 6560–50–P 

FEDERAL TRADE COMMISSION 

[File No. 151–0048] 

Drug Testing Compliance Group, LLC; 

Analysis To Aid Public Comment 

AGENCY: Federal Trade Commission. 

ACTION: Proposed consent agreement. 

SUMMARY: The consent agreement in this 

matter settles alleged violations of 

federal law prohibiting unfair methods 

of competition. The attached Analysis to 

Aid Public Comment describes both the 

allegations in the draft complaint and 

the terms of the consent order— 

embodied in the consent agreement— 

that would settle these allegations. 

DATES: Comments must be received on 

or before January 13, 2016. 

ADDRESSES: Interested parties may file a 

comment at https://ftcpublic.

commentworks.com/ftc/dtcgroup

consent online or on paper, by following 

the instructions in the Request for 

Comment part of the SUPPLEMENTARY

INFORMATION section below. Write ‘‘Drug 

Testing Compliance Group—Consent 

Agreement; File No. 151–0048’’ on your 

comment and file your comment online 

at https://ftcpublic.commentworks.com/

ftc/dtcgroupconsent by following the 

instructions on the web-based form. If 

you prefer to file your comment on 

paper, write ‘‘Drug Testing Compliance 

Group—Consent Agreement; File No. 

151–0048’’ on your comment and on the 

envelope, and mail your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW., Suite 

CC–5610 (Annex D), Washington, DC 

20580, or deliver your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW., 

5th Floor, Suite 5610 (Annex D), 

Washington, DC 20024. 

FOR FURTHER INFORMATION CONTACT: 

William Lanning (202–326–3361), 

Bureau of Competition, 600 

Pennsylvania Avenue NW., Washington, 

DC 20580. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 6(f) of the Federal Trade 

Commission Act, 15 U.S.C. 46(f), and 

FTC Rule 2.34, 16 CFR 2.34, notice is 

hereby given that the above-captioned 

consent agreement containing consent 

order to cease and desist, having been 

filed with and accepted, subject to final 

approval, by the Commission, has been 

placed on the public record for a period 

of thirty (30) days. The following 

Analysis to Aid Public Comment 

describes the terms of the consent 

agreement, and the allegations in the 

complaint. An electronic copy of the 

full text of the consent agreement 

package can be obtained from the FTC 

Home Page (for December 14, 2015), on 

the World Wide Web, at http://

www.ftc.gov/os/actions.shtm. 

You can file a comment online or on 

paper. For the Commission to consider 

your comment, we must receive it on or 

before January 13, 2016. Write ‘‘Drug 

Testing Compliance Group—Consent 

Agreement; File No. 151–0048’’ on your 

comment. Your comment—including 

your name and your state—will be 

placed on the public record of this 

proceeding, including, to the extent 

practicable, on the public Commission 

Web site, at http://www.ftc.gov/os/

publiccomments.shtm. As a matter of 

discretion, the Commission tries to 

remove individuals’ home contact 

information from comments before 

placing them on the Commission Web 

site. 

Because your comment will be made 

public, you are solely responsible for 

making sure that your comment does 

not include any sensitive personal 

information, like anyone’s Social 

Security number, date of birth, driver’s 

license number or other state 

identification number or foreign country 

equivalent, passport number, financial 

account number, or credit or debit card 

number. You are also solely responsible 

for making sure that your comment does 

not include any sensitive health 

information, like medical records or 

other individually identifiable health 

information. In addition, do not include 

any ‘‘[t]rade secret or any commercial or 

financial information which . . . is 

privileged or confidential,’’ as discussed 

in Section 6(f) of the FTC Act, 15 U.S.C. 

46(f), and FTC Rule 4.10(a)(2), 16 CFR 

4.10(a)(2). In particular, do not include 

competitively sensitive information 

such as costs, sales statistics, 

inventories, formulas, patterns, devices, 

mstockstill on DSK4VPTVN1PROD with NOTICES